@article{ART002175856},
author={송영훈 and 남선영 and Youngjin Choi and Jung Hwa Kim and KIM YOUNGSIK and Hyun-Ja Jeong},
title={Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug},
journal={CELLMED},
issn={3022-6805},
year={2012},
volume={2},
number={3},
pages={29-29}
TY - JOUR
AU - 송영훈
AU - 남선영
AU - Youngjin Choi
AU - Jung Hwa Kim
AU - KIM YOUNGSIK
AU - Hyun-Ja Jeong
TI - Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug
JO - CELLMED
PY - 2012
VL - 2
IS - 3
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 29
EP - 29
SN - 3022-6805
AB - The prevalence of allergic disease has been increasing over the past few decades in the majority of Western industrialized nations. There are some socioeconomic disparities regarding allergic disease status and management. Pyeongwee-San (KMP6) is Korean medicine for the treatment of gastrointestinal tract disease. It is known that KMP6 has an improving effect on the spleen and stomach functions in traditional Korean medical theory. Here, we hypothesized that KMP6 could be used to regulate the inflammatory reaction. We show the molecular mechanisms of Pyeongwee-San (KMP6) on inflammatory reactions. A molecular docking simulation showed that hesperidin, component of KMP6, regulate the enzymatic activity by interaction in the active site of caspase-1. KMP6 control the activity of caspase-1 in activated human mast cell line (HMC-1 cells). KMP6 reduced the expression of receptor interacting protein (RIP)-2 in HMC-1 cells. Thymic stromal lymphopoietin protein production and mRNA expression were inhibited by KMP6. In the activated HMC-1 cells, KMP6 suppressed the activation of mitogen-ativated protein kinase and nuclear factor-kappaB. In addition, KMP6 significantly inhibited the expression of inflammatory cytokines. Our findings indicate that KMP6 may attenuate allergic reactions via the regulation of caspase-1/RIP-2 signaling pathway. These studies will help advance the social welfare system.
KW - caspase-1;hesperidin;molecular docking simulation;Pyeongwee-San (KMP6);thymic stromal lymphopoietin
DO -
UR -
ER -
송영훈, 남선영, Youngjin Choi, Jung Hwa Kim, KIM YOUNGSIK and Hyun-Ja Jeong. (2012). Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug. CELLMED, 2(3), 29-29.
송영훈, 남선영, Youngjin Choi, Jung Hwa Kim, KIM YOUNGSIK and Hyun-Ja Jeong. 2012, "Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug", CELLMED, vol.2, no.3 pp.29-29.
송영훈, 남선영, Youngjin Choi, Jung Hwa Kim, KIM YOUNGSIK, Hyun-Ja Jeong "Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug" CELLMED 2.3 pp.29-29 (2012) : 29.
송영훈, 남선영, Youngjin Choi, Jung Hwa Kim, KIM YOUNGSIK, Hyun-Ja Jeong. Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug. 2012; 2(3), 29-29.
송영훈, 남선영, Youngjin Choi, Jung Hwa Kim, KIM YOUNGSIK and Hyun-Ja Jeong. "Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug" CELLMED 2, no.3 (2012) : 29-29.
송영훈; 남선영; Youngjin Choi; Jung Hwa Kim; KIM YOUNGSIK; Hyun-Ja Jeong. Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug. CELLMED, 2(3), 29-29.
송영훈; 남선영; Youngjin Choi; Jung Hwa Kim; KIM YOUNGSIK; Hyun-Ja Jeong. Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug. CELLMED. 2012; 2(3) 29-29.
송영훈, 남선영, Youngjin Choi, Jung Hwa Kim, KIM YOUNGSIK, Hyun-Ja Jeong. Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug. 2012; 2(3), 29-29.
송영훈, 남선영, Youngjin Choi, Jung Hwa Kim, KIM YOUNGSIK and Hyun-Ja Jeong. "Socioeconomic impact of traditional Korean medicine, Pyeongwee-San (KMP6) as an anti-allergic inflammatory drug" CELLMED 2, no.3 (2012) : 29-29.